Your browser doesn't support javascript.
loading
Assessment of Drug-Drug Interactions between Taspoglutide, a Glucagon-Like Peptide-1 Agonist, and Drugs Commonly Used in Type 2 Diabetes Mellitus: Results of Five Phase I Trials.
Bogman, Katrijn; Brumm, Jochen; Hofmann, Carsten; Giraudon, Mylène; Niggli, Markus; Sturm-Pellanda, Carolina; Sauter, Annette; Sturm, Stefan; Mangold, Bernhard; Schmitt, Christophe.
Afiliação
  • Bogman K; Department of Clinical Pharmacology, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche AG, Grenzacherstrasse 124, Basel, CH-4070, Switzerland. katrijn.bogman@roche.com.
  • Brumm J; Department of Biostatistics, Genentech, South San Francisco, CA, USA.
  • Hofmann C; Department of Clinical Pharmacology, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche AG, Grenzacherstrasse 124, Basel, CH-4070, Switzerland.
  • Giraudon M; Department of Clinical Pharmacology, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche AG, Grenzacherstrasse 124, Basel, CH-4070, Switzerland.
  • Niggli M; Department of Biostatistics, Pharma Development, F. Hoffmann-La Roche AG, Basel, Switzerland.
  • Sturm-Pellanda C; Department of Clinical Pharmacology, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche AG, Grenzacherstrasse 124, Basel, CH-4070, Switzerland.
  • Sauter A; Department of Biostatistics, Pharma Development, F. Hoffmann-La Roche AG, Basel, Switzerland.
  • Sturm S; Department of Clinical Pharmacology, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche AG, Grenzacherstrasse 124, Basel, CH-4070, Switzerland.
  • Mangold B; Department of Clinical Pharmacology, Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche AG, Grenzacherstrasse 124, Basel, CH-4070, Switzerland.
  • Schmitt C; , Mühlstrasse 23 A, Walluf, 65396, Germany.
Clin Pharmacokinet ; 58(9): 1205-1214, 2019 09.
Article em En | MEDLINE | ID: mdl-30968335
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Preparações Farmacêuticas / Diabetes Mellitus Tipo 2 / Peptídeo 1 Semelhante ao Glucagon Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Preparações Farmacêuticas / Diabetes Mellitus Tipo 2 / Peptídeo 1 Semelhante ao Glucagon Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Suíça